iomeprol has been researched along with Peripheral Arterial Disease in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Peripheral Arterial Disease: Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meyer, BC | 1 |
| Klein, S | 1 |
| Krix, M | 1 |
| Aschoff, AJ | 1 |
| Wacker, FK | 1 |
| Albrecht, T | 1 |
1 trial available for iomeprol and Peripheral Arterial Disease
| Article | Year |
|---|---|
Comparison of a standard and a high-concentration contrast medium protocol for MDCT angiography of the lower limb arteries.
Topics: Aged; Contrast Media; Dose-Response Relationship, Drug; Female; Humans; Iopamidol; Leg; Male; Middle | 2012 |